DIČ-Searching.cz

DIČ-Searching v


Všechny informace o:

                        
Jméno

Clinigen Pharma Limited

Adresa
Pitcairn House Crown Square
Centrum 100
Burton On Trent
DE14 2WW
VAT ID (DIČ) no VAT ID available
Company No. 07248508 Show on Companies House
Accountsaudit-exemption-subsidiary
last accounts made up to 30. červen 2022
Sector (SIC)99999 Dormant Company
Company Register Statusactive
KYC Check
KYC / PEP / AML request
This data is incorrect?
Sources: Company Register: Companies House (companieshouse.gov.uk)

Quick access

Persons with Significant Control (3)

Source: Companies House
gb-flag GB Clinigen Limited Status: Active Notified: 28/06/2017 Companies House Number: 06771928 Nature of Control
  • Ownership of shares - 75% or more
  • Ownership of voting rights - 75% or more
  • Right to appoint and remove directors
  • gb-flag GB Clinigen Group Plc Status: Ceased Notified: 06/04/2016 Ceased: 28/06/2017 Nature of Control
  • Ownership of shares - 75% or more
  • Ownership of voting rights - 75% or more
  • Right to appoint and remove directors
  • gb-flag GB Clinigen Holdings Limited Status: Ceased Notified: 28/06/2017 Ceased: 28/06/2017 Nature of Control
  • Ownership of shares - 75% or more
  • Ownership of voting rights - 75% or more
  • Right to appoint and remove directors
  • Officers (3)

    Source: Companies House
    Adair, Richard Edward Centrum 100, Burton On Trent Status: Active Notified: 30/04/2024 Role: Secretary
    Charton, Jerome Marie Joseph Centrum 100, Burton On Trent Status: Active Notified: 30/04/2024 Occupation: Director Role: Director Country of Residence: Switzerland Nationality: Swiss
    Paling, Richard John Centrum 100, Burton On Trent, Staffordshire Status: Active Notified: 24/08/2021 Date of Birth: 04/1970 Occupation: Group Financial Controller Role: Director Country of Residence: England Nationality: British

    Companies Controlled by This Company (1)

    gb-flag GB U L Medicines Limited Status: Active Notified: 25/06/2021 Companies House Number: 06120521 Nature of Control
  • Ownership of shares - 75% or more
  • Ownership of voting rights - 75% or more
  • Right to appoint and remove directors